Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Catalyzed Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939829B details a mild copper-catalyzed method for aryl trifluoromethyl thioethers, offering cost-effective routes for API intermediates and agrochemicals.
Patent CN105481738B reveals copper-catalyzed synthesis improving yield and safety. Enables cost reduction in fine chemical manufacturing and reliable supply chain.
Patent CN111138325A reveals a safe, copper-catalyzed route to tetra-substituted Z-beta-sulfonyl enamines using solid SO2 sources, offering reliable pharmaceutical intermediate supply.
Patent CN104193628A reveals a novel one-step synthesis for amino aryl ketones. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN112939829A reveals a copper-catalyzed method for aryl trifluoromethyl thioethers, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel four-component coupling method for high-purity maleimide intermediates offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN111978237A details a novel Cu-catalyzed four-component coupling for high-purity maleimide intermediates, offering significant cost reduction and supply chain reliability.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN111978237B reveals a copper-catalyzed four-component route for high-purity maleimide derivatives, offering significant cost and supply chain advantages.
Patent CN111269156B reveals a novel copper-catalyzed cross-coupling method for synthesizing 1,2,4-tricarbonyl sulfoxide ylides, offering mild conditions and high structural diversity for pharmaceutical applications.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. Achieve cost reduction in pharmaceutical intermediate manufacturing with high purity and scalability.
Patent CN113072478B details a mild copper-catalyzed N-arylation method using aryl silanes, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN111662147A reveals a green copper-catalyzed method for diacetylenes, offering cost reduction and scalable manufacturing for pharmaceutical and material science applications.
Patent CN111848480A details a copper-catalyzed method for synthesizing aryl difluoromethylselenyl ethers from boronic acids, offering cost-effective routes for drug discovery.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. This method offers significant cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Innovative copper(I)-catalyzed method for 1,3-enyne synthesis eliminates expensive palladium, offering high purity and scalable production for pharmaceutical intermediates.